Default: Thorax

ISSN: 0040-6376

Journal Home

Journal Guideline

Thorax Q1 Unclaimed

BMJ Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Thorax is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 221. It has an SJR impact factor of 3,083 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,083.

Thorax focuses its scope in these topics and keywords: sleep, obstructive, respiratory, health, disease, chronic, tuberculosis, patients, pulmonary, pneumonia, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Thorax

3,083

SJR Impact factor

221

H Index

219

Total Docs (Last Year)

690

Total Docs (3 years)

5350

Total Refs

3440

Total Cites (3 years)

469

Citable Docs (3 years)

4,32

Cites/Doc (2 years)

24,43

Ref/Doc

Aims and Scope


sleep, obstructive, respiratory, health, disease, chronic, tuberculosis, patients, pulmonary, pneumonia, risk, antigen, airway, copd, clinical, lung, questionnaire, infections, lower, pneumococcal, physical, pressure,



Best articles by citations

Squawks in pneumonia

View more

Rapid detection of pneumococcal antigen in pleural fluid of patients with community acquired pneumonia.

View more

Community-acquired pneumonia in children: what's new?

View more

Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients

View more

Inhibition of the alveolar macrophage oxidative burst by a diffusible component from the surface of the spores of the fungus Aspergillus fumigatus.

View more

Pulmonary pseudotumour due to Corynebacterium equi in a patient with the acquired immunodeficiency syndrome.

View more

Coming now to a chest clinic near you

View more

Highlights from this issue

View more

Prospective study of mycobacterial infections in patients with cystic fibrosis.

View more

Investigation of mycobacterial colonisation and invasion of the respiratory mucosa

View more

Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus.

View more

Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis

View more
SHOW MORE ARTICLES

Lymphangioleiomyomatosis: a case-control study of perinatal and early life events

View more

Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster

View more

Functional brain imaging in respiratory medicine

View more

Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin

View more

Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF

View more

Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial

View more

Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping

View more

Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.

View more

Cryptococcosis in HIV negative patients: findings on chest radiography

View more

Disseminated Penicillium marneffei infection presenting as a right upper lobe mass in an HIV positive patient

View more

Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis.

View more

Effect of bacterial products on human ciliary function in vitro.

View more

Comments

No comments ... Be the first to comment!

FAQS